Disease | Outcome | Index date post IFX initiation | Disease worsening at subsequent visits, n/N (%) | |
---|---|---|---|---|
12 months | 24 months | |||
AS | ASDAS | 2 years | 9/79 (11.4%) | 6/59 (10.2%) |
4 years | 2/42 (4.8%) | 1/37 (2.7%) | ||
6 years | 1/25 (4.0%) | 2/18 (11.1%) | ||
RA | DAS28 ESR | 2 years | 20/184 (10.9%) | 17/148 (11.5%) |
4 years | 9/121 (7.4%) | 7/106 (6.7%) | ||
6 years | 8/73 (11.0%) | 5/47 (10.6%) | ||
DAS28 CRP | 2 years | 16/160 (10.0%) | 11/124 (8.9%) | |
4 years | 8/115 (7.0%) | 6/104 (5.9%) | ||
6 years | 6/80 (7.5%) | 4/54 (7.4%) |